Table V.7: The Number of States Reporting Each Level of Satisfaction with FDA Communication Regarding Drug Compounding
Number of statesa
Very satisfied Somewhat satisfied Neither satisfied nor dissatisfied Somewhat dissatisfied Very dissatisfied No response
17 7 5 7 2 2

Source: GAO survey of state pharmacy regulatory bodies, survey question 36. | GAO-17-363SP
Notes: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey.
aForty states that reported having had communication or interactions with the Food and Drug Administration (FDA) related to drug compounding issues were asked about their overall satisfaction with that communication or interaction.